Deepinder Goyal Tests Experimental Brain Health Device Called Temple

Deepinder Goyal, founder and CEO of Zomato, recently appeared on Raj Shamani’s Figuring Out podcast wearing a small metallic device on his temple that drew widespread attention. The device, called Temple, is an experimental wearable designed to monitor brain blood flow in real time.

It is being developed under Eternal, Goyal’s personal research-focused company, and is not available for public purchase. Goyal confirmed that he has been testing the device for nearly a year as part of a broader scientific initiative.

What Is Temple and Its Purpose?

Temple is a prototype wearable aimed at tracking cerebral blood flow continuously to study neurological health and ageing. Brain blood flow is considered a key marker of cognitive well-being, particularly as individuals age.

The device is not intended for commercial use and remains in the research phase. According to Goyal, the goal is to generate data that could help understand how blood circulation patterns influence brain health over time.

The Gravity Ageing Hypothesis

The concept behind Temple emerged while Goyal’s team was exploring the Gravity Ageing Hypothesis. This theory suggests that gravity’s pull over decades may affect blood circulation to the brain and potentially influence ageing.

While the hypothesis has sparked interest, experts caution that ageing is a complex process and cannot be attributed to gravity alone. Goyal emphasised that the research is exploratory and intended to push scientific boundaries rather than provide definitive answers.

Investment And Research Initiative

Reports suggest that Goyal has invested about $25 million, or roughly ₹225 crore, of his personal wealth into Continue Research, which is spearheading Temple’s development. He has clarified that the funding is personal in nature and experimental.

The initiative is focused on advancing curiosity-driven scientific research rather than creating a consumer-facing product. The work is expected to progress through iterative testing and data analysis, with no immediate plans for commercialisation.

Broader Implications and Next Steps

Temple represents a growing trend of private individuals funding deep-tech research in areas such as neuroscience and ageing. While the device remains in early stages, its focus on brain health aligns with global interest in longevity and cognitive well-being.

Detailed findings from the project have not yet been published, and the timeline for further development remains undisclosed. Goyal’s involvement underscores a commitment to scientific exploration beyond traditional business ventures.

Read More: OpenAI Becomes the Highest-Paying Tech Startup.

Conclusion

Deepinder Goyal’s experimental device Temple has sparked curiosity about brain health and ageing research. Developed under Eternal and funded through Continue Research, the wearable aims to study cerebral blood flow and its role in cognitive longevity.

Though still in its pilot phase, the initiative highlights the intersection of technology, health, and private research funding. Future updates will depend on ongoing trials and scientific validation.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.